Trial Profile
An observational, prospective study to evaluate the pharmacokinetics and pharmacodynamics of voriconazole in critically ill patients with pulmonary diseases in China
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Voriconazole (Primary)
- Indications Aspergillosis; Candidiasis; Fusariosis
- Focus Pharmacodynamics; Pharmacokinetics
- 28 Apr 2016 New trial record